Fennec Pharmaceuticals develops and sells PEDMARK, a sodium thiosulfate injection, from Research Triangle Park, North Carolina. It last closed at $13.58 on Nov 17, up 6.43% on the day. The average 12-month price target from 2 analysts is $17.50 (+28.9% from the last close), with a high of $19.00 and a low of $16.00.
Only 2 firms rated FENC in the past 90 days, not enough for a consensus
Average 12-month target
$17.50
▲ 28.9% upside
Based on 2 analysts who set a price target on FENC in the past 90 days. The average target is $17.50, with a high of $19.00 and a low of $16.00, compared with the last close of $13.58.
Low $16.00Avg $17.50High $19.00
Blue marker: last close $13.58
Highest target$19.00
Average target$17.50
Lowest target$16.00
Latest rating changes
B. Riley SecuritiesTarget raised
Nov 16Buy$18 → $19
HC Wainwright & Co.Reiterated
Sep 9Buy$16
B. Riley SecuritiesReiterated
Aug 12Buy$18
WedbushMaintained
Aug 12Buy$16
HC Wainwright & Co.Maintained
May 22Buy$16
Date
Firm
Action
Rating
Price target
Nov 16
B. Riley Securities
Target raised
Buy
$18 → $19
Sep 9
HC Wainwright & Co.
Reiterated
Buy
$16
Aug 12
B. Riley Securities
Reiterated
Buy
$18
Aug 12
Wedbush
Maintained
Buy
$16
May 22
HC Wainwright & Co.
Maintained
Buy
$16
Loading…
Technical Analysis
FENC · as of the Nov 17 close · updated after every close
Uptrend, overbought
The stock is 21% above its 20 day and 21% above its 50 day average. It is 31% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 73), overbought. The nearest support is the Pivot at $13.27, and the nearest resistance the 52 week high at $13.63.
Short trendBullish
Long trendBullish
MomentumStrong
StretchOverbought
VolatilityHigh, 5.7%/day
Key levels
$13.94Pivot R1+2.7%
$13.6352 week high+0.4%
$13.58Last close
$13.27Pivot−2.3%
$12.91Pivot S1−4.9%
$10.88Swing low (Aug 24)−19.9%
$10.86100 day average−20.0%
$10.7720 day average−20.7%
$10.6750 day average−21.4%
$9.41200 day average−30.7%
$5.6552 week low−58.4%
Indicators
RSI (14)
72.84
Overbought above 70
Overbought
MACD
0.44
Above its signal line
Bullish
Stochastic
92.8
Near the top of its range
Overbought
ADX (14)
19.9
No clear trend
Williams %R
-1.1
Oversold below −80, overbought above −20
Overbought
CCI (20)
302.4
Oversold below −100, overbought above 100
Overbought
Rate of change
+26.9%
Change over 10 sessions
Bullish
ATR (14)
$0.77
Typical daily range, 5.7% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Uptrend, nearing overbought
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 9.9%/day
Key levels
$13.94Pivot R1+2.7%
$13.6352 week high+0.4%
$13.58Last close
$13.27Pivot−2.3%
$12.91Pivot S1−4.9%
$10.88Swing low (Aug 24)−19.9%
$10.86100 day average−20.0%
$10.7720 day average−20.7%
$10.6750 day average−21.4%
$9.41200 day average−30.7%
$5.6552 week low−58.4%
Indicators
RSI (14)
67.59
Strong, overbought above 70
Neutral
MACD
0.59
Above its signal line
Bullish
Stochastic
57.9
Middle of its range
Neutral
ADX (14)
25.3
Trending up
Williams %R
-1.1
Oversold below −80, overbought above −20
Overbought
CCI (20)
202.3
Oversold below −100, overbought above 100
Overbought
Rate of change
+23.9%
Change over 10 sessions
Bullish
ATR (14)
$1.34
Typical daily range, 9.9% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for FENC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how FENC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow FENC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How FENC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FENC is in one of them and how their past FENC trades turned out.
Fennec Pharmaceuticals is a pharmaceutical company based in Research Triangle Park, North Carolina. Its main product is PEDMARK, a sodium thiosulfate injection that the company develops and commercializes. The company relies on patents and licensed intellectual property to protect PEDMARK from competing generic versions. It works with licensors and collaborators on its technologies and product.